Clinical trials data
N-Back Task in substance use and addiction trials: 68 registered studies
Every registered substance use and addiction study on ClinicalTrials.gov that names the N-Back Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered substance use and addiction studies name it in an outcome measure
- 68
- Name it in a primary outcome, 54%
- 37 of 68
Tests named in the same studies
- 1
Stop-Signal Task12 studies, 7 as a primary outcome
- 2
Continuous Performance Test9 studies, 4 as a primary outcome
- 3
Go/No-Go Task7 studies, 4 as a primary outcome
- 4
Verbal Learning6 studies, 4 as a primary outcome
- 5
Delay Discounting6 studies, 2 as a primary outcome
- 6
Digit Span Test5 studies, 4 as a primary outcome
- 7
Eriksen Flanker Task5 studies, 4 as a primary outcome
- 8
AX Continuous Performance Test5 studies, 1 as a primary outcome
- 9
Balloon Risk4 studies, 2 as a primary outcome
- 10
Cue Reactivity Task4 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 3 | 2 |
| 2008 | 2 | 0 |
| 2009 | 0 | 0 |
| 2010 | 3 | 2 |
| 2011 | 4 | 1 |
| 2012 | 3 | 0 |
| 2013 | 3 | 3 |
| 2014 | 2 | 2 |
| 2015 | 1 | 1 |
| 2016 | 6 | 4 |
| 2017 | 6 | 4 |
| 2018 | 8 | 5 |
| 2019 | 4 | 2 |
| 2020 | 2 | 1 |
| 2021 | 3 | 2 |
| 2022 | 3 | 2 |
| 2023 | 4 | 2 |
| 2024 | 4 | 2 |
| 2025 | 4 | 0 |
| 2026 | 3 | 2 |
Phases and study sizes
By phase
- Early phase 14 studies, 3 as a primary outcome
- Phase 18 studies, 4 as a primary outcome
- Phase 1/22 studies, 0 as a primary outcome
- Phase 215 studies, 7 as a primary outcome
- Phase 31 studies, 1 as a primary outcome
- Phase 41 studies, 0 as a primary outcome
- Not applicable31 studies, 17 as a primary outcome
- Observational6 studies, 5 as a primary outcome
Participants per study
- Phase 233 median, 19 to 80
- Not applicable64 median, 38 to 121
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 13 | 33 | 19 to 80 |
| Not applicable | 30 | 64 | 38 to 121 |
When substance use and addiction trials measure it
Latest time point of each outcome
- Within a day20 outcomes, 14 as a primary outcome
- Up to 4 weeks20 outcomes, 11 as a primary outcome
- 1 to 3 months16 outcomes, 6 as a primary outcome
- 3 to 6 months2 outcomes, 1 as a primary outcome
- 6 to 12 months3 outcomes, 1 as a primary outcome
- 1 to 2 years2 outcomes, 1 as a primary outcome
- Over 2 years2 outcomes, 2 as a primary outcome
- No duration given2 outcomes, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
65 of the 67 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting11 studies, 5 as a primary outcome
- Not yet recruiting1 studies, 0 as a primary outcome
- Active, not recruiting2 studies, 2 as a primary outcome
- Completed41 studies, 23 as a primary outcome
- Stopped early8 studies, 4 as a primary outcome
- Status unknown5 studies, 3 as a primary outcome
What they test
- Behavioral15 studies, 9 as a primary outcome
- Drug37 studies, 20 as a primary outcome
- Device15 studies, 7 as a primary outcome
- Dietary supplement2 studies, 0 as a primary outcome
- Procedure1 studies, 0 as a primary outcome
- Other10 studies, 7 as a primary outcome
- None given1 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States44 studies, 28 as a primary outcome
- Canada6 studies, 2 as a primary outcome
- Germany4 studies, 4 as a primary outcome
- China3 studies, 2 as a primary outcome
- Brazil2 studies, 0 as a primary outcome
- Switzerland2 studies, 1 as a primary outcome
- United Kingdom2 studies, 0 as a primary outcome
- Australia1 studies, 0 as a primary outcome
- Spain1 studies, 0 as a primary outcome
- Taiwan1 studies, 0 as a primary outcome
10 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed substance use and addiction studies that name the N-Back Task: 27 of 41, 66%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed substance use and addiction studies that name the N-Back Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 5, 12% | 776, 10% |
| Results on ClinicalTrials.gov only | 15, 37% | 1,139, 14% |
| A results paper only | 7, 17% | 1,711, 22% |
| Neither | 14, 34% | 4,327, 54% |
The 68 studies
68 studies match. 37 name the N-Back Task in a primary outcome. Median size 50 participants. Median time to the primary outcome: 2 weeks.
Loading 68 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 3 | 2 |
| 2008 | 2 | 0 |
| 2009 | 0 | 0 |
| 2010 | 3 | 2 |
| 2011 | 4 | 1 |
| 2012 | 3 | 0 |
| 2013 | 3 | 3 |
| 2014 | 2 | 2 |
| 2015 | 1 | 1 |
| 2016 | 6 | 4 |
| 2017 | 6 | 4 |
| 2018 | 8 | 5 |
| 2019 | 4 | 2 |
| 2020 | 2 | 1 |
| 2021 | 3 | 2 |
| 2022 | 3 | 2 |
| 2023 | 4 | 2 |
| 2024 | 4 | 2 |
| 2025 | 4 | 0 |
| 2026 | 3 | 2 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 1, NIH 1, other 66. Interventional 62, observational 6.
As a primary outcomeSecondary or other outcomeThe N-Back Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07802990 | Start2026 | PhasePhase 1/2 | ConditionsSubstance use and addiction | Participants28 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07734623 | Start2025 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07532460 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07510113 | Start2025 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants38 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07296874 | Start2026 | PhasePhase 1 | ConditionsSubstance use and addiction | Participants92 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07001930 | Start2025 | PhasePhase 1 | ConditionsSubstance use and addiction | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06977178 | Start2024 | PhaseNot applicable | ConditionsSubstance use and addiction, Anxiety, PTSD and OCD | Participants180 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06837649 | Start2023 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants66 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06798324 | Start2025 | PhasePhase 4 | ConditionsSubstance use and addiction | Participants160 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06346353 | Start2024 | PhaseObservational | ConditionsDepression and bipolar disorder, Substance use and addiction, Anxiety, PTSD and OCD | Participants756 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06326684 | Start2024 | PhaseEarly phase 1 | ConditionsSubstance use and addiction | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06299787 | Start2022 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Substance use and addiction | Participants40 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06286774 | Start2024 | PhaseNot applicable | ConditionsSubstance use and addiction, Sleep and sleep disorders | Participants256 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05976672 | Start2023 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants500 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT05903495 | Start2023 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants1 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05387148 | Start2022 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants20 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05170217 | Start2017 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants46 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05062369 | Start2022 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05048758 | Start2021 | PhaseObservational | ConditionsSubstance use and addiction | Participants43 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04964843 | Start2023 | PhasePhase 2 | ConditionsSubstance use and addiction | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT04856566 | Start2021 | PhaseEarly phase 1 | ConditionsSubstance use and addiction | Participants41 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04725617 | Start2021 | PhaseNot applicable | ConditionsSubstance use and addiction, Sleep and sleep disorders, Cardiovascular disease | Participants200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT04498988 | Start2014 | PhaseObservational | ConditionsSubstance use and addiction | Participants338 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04296604 | Start2014 | PhaseNot applicable | ConditionsBrain injury and concussion, Schizophrenia and psychosis, Depression and bipolar disorder, ADHD, Substance use and addiction | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT04202926 | Start2019 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants23 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many substance use and addiction trials use the N-Back Task?
68 registered substance use and addiction studies on ClinicalTrials.gov name it in an outcome measure, 37 of them in a primary outcome: 8% of the condition's 895 studies with a cognitive outcome, against 5% of all of them. It is the 8th most named test in substance use and addiction trials.
Which tests do substance use and addiction trials use with the N-Back Task?
The Stop-Signal Task (12 studies), the Continuous Performance Test (9 studies) and the Go/No-Go Task (7 studies).
How many participants do phase 2 substance use and addiction trials that use the N-Back Task enroll?
Half of the phase 2 studies that name it enroll 33 participants or fewer, and the middle half enroll 19 to 80. 13 of them give a size.
When do substance use and addiction trials measure the N-Back Task?
Half of the primary outcomes that name the N-Back Task are measured within 2 weeks of the start, and the middle half from the first day to 5 weeks. 36 primary outcomes give a duration.
How many completed substance use and addiction trials that use the N-Back Task have reported results?
27 of the 41 completed studies that name it, 66%, have reported results: 20 posted them on ClinicalTrials.gov, 12 have a results paper linked to the registry record, and 5 did both. The other 14 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts 1-Back Task and 2-Back Task as one test family, so this page counts their studies together.
Run the N-Back Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.